Analyst Ratings for Monopar Therapeutics (MNPR)
MNPR Rating Summary
MNPR Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$111.15 (0%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
130.00 (N/A) |
55.13 (111.12) |
101.56% | Details |
| 1/9/2026 | Morgan Stanley | Maxwell Skor | New Coverage | Overweight (N/A) |
115.00 (N/A) |
65.01 (111.12) |
70.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
